Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum Immunoprecise Antibodies Ltd IPA

ImmunoPrecise Antibodies Ltd. is a biotechnology company that leverages multi-omics modeling and complex artificial intelligence through a series of proprietary and patented technologies. The Company owns an integrated end-to-end suite of capabilities to support the development of therapeutic antibodies. It has several subsidiaries in North America and Europe including entities, such as Talem... see more

NDAQ:IPA - Post Discussion

Immunoprecise Antibodies Ltd > Well this didn't go as planned
View:
Post by Right80% on Dec 30, 2020 1:48pm

Well this didn't go as planned

However, I feel this creates another buying opportunity before this company gets on the US institutions radar. Until this point buying the way up seems to be a way this one works. So this sould be viewed as a gift. JMHO
Comment by wallpaper2 on Dec 31, 2020 10:44am
It went up the past 2-3 weeks on excitement and anticipation of a instant gap upwards in the share price on Dec.30th. The next set of trials has yet to be announced but is supposed to start sometime in January? I was told the trials will take at least 2 weeks to conduct and it will take a further 2 weeks to analyze them. So what are we left with.......  disappointment and a falling share ...more  
Comment by bigreturn11 on Dec 31, 2020 11:17am
I think we are left with excitement of a potential therapeutic that would be unmatched in the globe. Imagine positive phase I results at the end of January. Then heading into Phase II - if the Phase II results looks promising the opportunity at the current share price is significant. This is the excitement..... In a couple short months this thing could go wayyy higher than previous all time ...more  
Comment by wallpaper2 on Dec 31, 2020 11:26am
I hope it happens. The good news is:  news will leak out after the 2 week trials end and if they appear strong it will move up very quickly again on even more excitement.
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities